Spiga

About Circumcision Rates Too Low

"There's a good case to be made that circumcisions can protect our children," said study author Arleen A. Leibowitz, a professor of public policy at the University of California, Los Angeles. "If you can alleviate the cost of the procedure, then people are more likely to adopt it."

Circumcision rates have been dropping since the 1980s amid controversy about whether the procedure is necessary or desirable. More states, meanwhile, have stopped paying for the procedure through Medicaid, including 10 in this decade alone. If all states covered circumcision, the percentage of male babies who get the procedure would rise from 56 percent to 62 percent, Leibowitz estimated.

Critics say circumcision is brutal and robs males of sexual sensation, but many in the medical community point to research that suggests circumcision reduces the risk of sexually transmitted diseases such as AIDS and the virus that can cause cervical cancer.

Currently, 16 states don't cover circumcision through their Medicaid programs, according to the new study. The procedure for an infant can cost $250 to $300, Leibowitz said.

Circumcision rates among Latinos are especially low, even if the government pays for the procedure, Leibowitz said. She added that rates are about equal among whites and blacks.

The study authors looked at a national sample of 417,282 newborn boys from 2004. The researchers examined the statistics with an eye toward whether the states where the boys were born covered circumcision.

The findings were published in the January issue of the American Journal of Public Health.

According to Leibowitz, the states that don't cover the procedure are: Arizona, California, Florida, Idaho, Louisiana, Maine, Minnesota, Mississippi, Missouri, Montana, Nevada, North Carolina, North Dakota, Oregon, Utah and Washington.

The researchers adjusted the numbers to account for factors such as the number of days that infants spent in the hospital. According to Leibowitz, it's difficult to fit in a circumcision if the baby is just there for a day.

Even with the adjustments, circumcision rates were significantly lower in states that didn't pay for the procedure through Medicaid, she said, adding that "not covering it under Medicaid sends a signal to recipients that this not a valuable procedure."

Robert C. Bailey, a professor of epidemiology at the University of Illinois at Chicago, said the poor are robbed of a chance to make a choice about circumcision because of the lack of funding.

"It's another way in which our health system is increasing inequality across the population," he said. "People who can't afford good health care are essentially being discriminated against by this policy."

SOURCES: Arleen A. Leibowitz, Ph.D., professor, public policy, University of California, Los Angeles; Robert C. Bailey, Ph.D., professor, epidemiology, University of Illinois at Chicago; January 2009, American Journal of Public Health.

Info about CDC Warns of Drug-Resistant Flu Bug

Flu is a dangerous and sometimes deadly disease. But the Tamiflu-resistant strain isn't any more or less dangerous than other flu strains.

The Tamiflu-resistant virus is the flu bug most commonly seen so far this year. It's been detected in 12 states so far, mostly in Hawaii and Texas.

Tamiflu resistance wasn't unexpected. What was surprising was the rapid rise of Tamiflu resistance in this particular flu bug. Last year, about 11% of type A H1N1 flu bugs were resistant. So far this year, 49 out of 50 H1N1 viruses have been resistant.

Even so, it's still very early in the flu season. There's no way to know whether the Tamiflu-resistant flu bug will be this year's predominant cause of flu.

"There is no crystal ball here," CDC Director Julie Gerberding, MD, tells WebMD. "We can't predict if this strain will end up being the most important one this year. It could fizzle out. ... We're giving a 'heads-up' to the clinicians, but we are not making drastic changes in our treatment and prevention recommendations."

Three different flu bugs are in circulation among humans. The resistant bug is the type A H1N1 strain. There's also the type A H3N2 strain, and one type B strain.

The current flu vaccine protects against all three of these viruses -- and the current flu vaccine is an excellent match for the drug-resistant bug, Gerberding says.

Fortunately, the Tamiflu-resistant flu bug is still sensitive to Relenza, an alternative flu drug of the same basic type as Tamiflu. And the bug may also be sensitive to the older flu drugs Flumadine and Symmetrel, although resistance to these drugs has been steadily increasing among type A flu bugs.

Flu drugs can be used both to treat and to prevent the flu:

  • Treatment with flu drugs must begin no later than two days after symptoms appear. The earlier that treatment begins, the shorter and less severe the illness.
  • Prevention with flu drugs is used in households, hospitals, or facilities (such as nursing homes) where people have been exposed to someone who has the flu.

Tamiflu has been the most attractive treatment because it is taken in pill form and can be given to children as young as 1 year old.

Relenza comes in an inhaler. Children younger than 7 can't use it for treatment, and those younger than 5 can't use it for prevention. Moreover, Relenza sometimes causes lung spasms, so it can't be used by people with lung problems.

Ironically, the CDC's Tamiflu warning is not going to make a huge difference in how patients are treated because too few people get treated with flu drugs, says Joseph S. Bresee, MD, chief of the epidemiology and prevention branch of the CDC's flu division.

"Even among hospital patients with the flu, more than half do not receive antiviral therapy," Bresee tells WebMD. "[Tamiflu] and [Relenza] are relatively underused at this point."

Bresee suggests that the current warning might actually increase use of flu drugs by making doctors more aware of how to use them.

Here's what the CDC now recommends:

  • Doctors should keep track of the subtypes of flu virus circulating in their areas. The CDC offers weekly updates based on reports from local and state health agencies.
  • When testing patients for the flu, doctors should consider using tests that can tell type A flu from type B flu.
  • Use Tamiflu alone only if the main flu bugs in the area are type A H3N2 or type B.
  • If drug-resistant virus is circulating in the area, use Relenza. In patients unable to take Relenza, doctors may use a combination of Tamiflu and Flumadine (or Symmetrel if Flumadine isn't available).

But here's the best advice: It's not too late to get a flu shot (or sniff, via the inhaled FluMist vaccine). Flu season rarely peaks before February -- and lots of people come down with the flu as late as March or April. So if you've been putting off getting your flu shot, now is the time to act.

SOURCES: CDC Health Advisory, Dec. 19, 2008. Julie Gerberding, MD, MPH, director, CDC. Timothy M. Uyeki, MD, medical epidemiologist, influenza branch, CDC. Joseph S. Bresee, MD, chief of epidemiology and prevention, influenza branch, CDC.